Mitochondrial Protein Fuels Spread of Head and Neck Cancer

Head and neck cancer cells lacking the peptide involved in energy production were less likely to metastasize in mice.

Written byPatience Asanga
| 3 min read
An illustration of a mitochondrion, represented by a purple and orange bilayer, synthesizing reddish molecules of ATP.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Within mitochondria, specialized proteins work together to produce energy. Most eukaryotic cells live off of this energy–including cancerous cells, researchers have now found. In a June 29 study published in Nature, a team of scientists concludes that head and neck cancer cells fuel their journey to colonize new locations throughout the body with energy derived from modifying a key mitochondrial protein called NSUN3. The researchers say that NSUN3 is critical for generating energy in the mitochondria and that the protein’s absence confines cancerous cells to their primary tumors.

Before now, cancer cells were known to develop with the energy produced through glycolysis, despite the fact that glycolysis is an inefficient way of making energy. In this study, the researchers found that cells in a primary tumor only tilt toward glycolysis as a backup when there is a shortage of NSUN3 protein in the mitochondria, and that doing so inhibits metastasis.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • black and white headshot of a woman
    Patience is a Nigeria-based freelance science journalist who writes about the environment, biotechnology, and life sciences. She is also the editor of aebsan, a student-run news outlet operated out of the University of Benin, Nigeria. Her writing has featured in aebsan, ICJS, and theGIST.
    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies